Candida auris is emerging as a prevalent urinary pathogen
PLOS Pathogens · 2025
DOI: 10.1371/journal.ppat.1013138 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Pathogens, 2025. Verfasst von Alyssa Ann La Bella und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, University of Notre Dame, Notre Dame, Indiana, United States of America. Hauptthemen laut MEDLINE: Urinary Tract Infections, Candidiasis, Candida auris, Catheter-Related Infections. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIAID NIH HHS.
Abstract (Originalsprache)
Urinary tract infections (UTIs) are one of the most common infections, with a subgroup of these infections, catheter-associated UTIs (CAUTIs), accounting for 40% of nosocomial infections. While the majority of CAUTI pathogens are bacterial, the second most common pathogen is the fungus Candida albicans. However, in recent years, Candida auris has increasingly been isolated from urine, indicating C. auris’ potential as a urinary pathogen. C. auris has rapidly emerged as a human pathogen worldwide, becoming a serious health threat. This is of great concern due to its antifungal resistance, adherence to inanimate surfaces, high mortality rates, and the extensive knowledge gap regarding C. auris’ prevalence and pathophysiology. To understand whether C. auris is prevalent in the urinary tract, we analyzed 12,996 C. auris clinical strains and their frequency related to urine and urinary catheters. We identified urine as the second most common C. auris isolation source in the United States and the third most common worldwide. Anecdotally, C. auris urine isolates are often associated with urinary catheters and high mortality rates. Furthermore, there has been an early indication of urinary isolates developing echinocandin resistance. With the increasing incidence of uropathogenic C. auris , it is critical to have an in-depth understanding of C. auris pathogenesis in the urinary tract to effectively prevent and treat these infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biological Sciences, University of Notre Dame, Notre Dame, Indiana, United States of America.
ORCID-Profile: Ana Lidia Flores-Mireles
Förderung
- NIDDK NIH HHS
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- NIAID NIH HHS
- Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases
- Open Philanthropy
- Arthur J. Schmitt Foundation
- Eck Institute for Global Health, University of Notre Dame
Zitieren
APA
La Bella, A. A., Santiago-Tirado, F. H., & Flores-Mireles, A. L. (2025). Candida auris is emerging as a prevalent urinary pathogen. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1013138
Vancouver
La Bella AA, Santiago-Tirado FH, Flores-Mireles AL. Candida auris is emerging as a prevalent urinary pathogen. PLOS Pathogens. 2025. doi:10.1371/journal.ppat.1013138
BibTeX
@article{LaBella2025,
author = {La Bella, Alyssa Ann and Santiago-Tirado, Felipe Hiram and Flores-Mireles, Ana Lidia},
title = {Candida auris is emerging as a prevalent urinary pathogen},
journal = {PLOS Pathogens},
year = {2025},
doi = {10.1371/journal.ppat.1013138}
}
EUVIMED